Jean Frydman To Serve on FDLI Academic Programs Committee

April 27, 2016 – Press Releases

Fox Rothschild LLP is pleased to announce that Partner Jean W. Frydman has been appointed to serve a three-year term on the Academic Programs Committee of the Food and Drug Law Institute (FDLI), effective May 1, 2016.

Founded in 1949, FDLI is a nonprofit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction.

As a committee member, Frydman will advise the FDLI on formulating and implementing policies and strategies to enhance its programs and publications as well as drive program idea generation, identify areas of need and promote FDLI activities.

A former general counsel for multinational pharmaceutical companies and a multinational retail dietary supplement company, Frydman possesses an in-depth knowledge of the regulatory and compliance issues facing clients in the pharmaceutical, medical device and dietary supplement industries. She has more than 30 years of experience handling regulatory compliance matters for both private and publicly held pharmaceutical, medical device and dietary supplement companies.

Frydman has extensive experience in drug, medical device and dietary supplement promotional review and advises senior management on new Food and Drug Administration (FDA) rules, proactive submissions to the FDA, Current Good Manufacturing Practice (cGMP) compliance and other significant enforcement issues. She regularly counsels clients on commercial and regulatory/compliance efforts, helping to establish and execute comprehensive compliance programs as well as implement strategies to manage and reduce legal expenses.

Frydman earned her J.D. from Chicago-Kent College of Law, her M.A., summa cum laude, from Central Michigan University and her B.S. from Ohio State University.